Literature DB >> 19003322

Diverse effects of the cyclin-dependent kinase inhibitor bohemine: Concentration- and time-dependent suppression or stimulation of hybridoma culture.

F Franek1, M Strnad, L Havlícek, V Siglerová, I Fismolová, T Eckschlager.   

Abstract

An analog of aromatic cytokinins, the 2,6,9-trisubstituted purine derivative bohemine, was applied to cultures of mouse hybridoma cells in order to analyze its capacity of suppressing cell growth and maintaining or enhancing the production of monoclonal antibody. Addition of bohemine at concentrations in the range of1-10 muM resulted in a short-term arrest of growth and of monoclonal antibody production. The short-term suppression of cell functions was followed by a significant temporary increase of specific growth rate and of specific production rate. The steady-state viable cell density values, found in semicontinuous cultures, showed a certain stimulation of cell growth in the range of micromolar concentrations of bohemine, and inhibition of growth at 10 and 30 muM concentrations. The profiles of cell cycle phases indicated that hybridoma cells are retarded both at the G(1)/S boundary and at the G(2)/M boundary, depending on bohemine concentration. The existence of the sequence of events,from suppression to stimulation, suggests that bohemine probably modulates more than one regulatory pathway in the cell.

Entities:  

Year:  2001        PMID: 19003322      PMCID: PMC3449669          DOI: 10.1023/A:1014020415912

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  24 in total

1.  Cell suicide in starving hybridoma culture: survival-signal effect of some amino acids.

Authors:  F Franěk; K Srámková
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

2.  Myoseverin, a microtubule-binding molecule with novel cellular effects.

Authors:  G R Rosania; Y T Chang; O Perez; D Sutherlin; H Dong; D J Lockhart; P G Schultz
Journal:  Nat Biotechnol       Date:  2000-03       Impact factor: 54.908

3.  Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.

Authors:  L Havlícek; J Hanus; J Veselý; S Leclerc; L Meijer; G Shaw; M Strnad
Journal:  J Med Chem       Date:  1997-02-14       Impact factor: 7.446

Review 4.  Cyclins and cyclin-dependent kinases: a biochemical view.

Authors:  J Pines
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

5.  Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine.

Authors:  W F De Azevedo; S Leclerc; L Meijer; L Havlicek; M Strnad; S H Kim
Journal:  Eur J Biochem       Date:  1997-01-15

Review 6.  Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs.

Authors:  M Hajdúch; L Havlíèek; J Veselý; R Novotný; V Mihál; M Strnad
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

7.  Docking-based development of purine-like inhibitors of cyclin-dependent kinase-2.

Authors:  M Otyepka; V Krystof; L Havlícek; V Siglerová; M Strnad; J Koca
Journal:  J Med Chem       Date:  2000-06-29       Impact factor: 7.446

8.  Regulation of cell growth by IRF-1 in BHK-21 cells.

Authors:  S Kirchhoff; A Kröger; H Cruz; M Tümmler; F Schaper; M Köster; H Hauser
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

Review 9.  Effects of sodium butyrate, a new pharmacological agent, on cells in culture.

Authors:  J Kruh
Journal:  Mol Cell Biochem       Date:  1982-02-05       Impact factor: 3.396

10.  On-line monitoring of monoclonal antibody formation in high density perfusion culture using FIA.

Authors:  C Fenge; E Fraune; R Freitag; T Scheper; K Schügerl
Journal:  Cytotechnology       Date:  1991-05       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.